Storage, Stability and Handling
Indications and Serious Warnings
Adverse Events
Dosage and Administration
Bonus (Double Points)
100

How should HyQvia be stored? 

Hyqvia should be stored in a refrigerator between 2 and 8 degrees C

100

HyQvia is indicated as a replacement therapy for patients diagnosed with what? 

Primary humoral Immunodeficiency and Secondary humoral Immunodeficiency 

100

This was the most frequently reported adverse reaction reported in clinical trials.

Site reactions 

100

What is the ONLY route of administration HyQvia is approved for?

Subcutaneous administration 

100

How does HyQvia work?

HyQvia is used for patients who do not have enough antibodies in their blood or have weakened immune systems. Regular HyQvia infusions raise abnormally low immunoglobulin levels in the blood to normal levels (replacement therapy). 

200

When Hyqvia is removed from the fridge it should be allowed to do this before use.

warm up to room temperature

200

Health Canada has NOT authorized an indication for use in these patients at this time. 

1. Pediatric 

2. Neuro 

3. Fertility 

200

There are over 15 common reactions observed in over 5% of patients during clinical trials. Name three common adverse reactions a patient may experience.

1. Nausea

2. Abdominal pain

3. Diarrhea

4. Vomiting

5. infusion site pain

6. Infusion site erythema (skin reaction)

7. Infusion site swelling

8. Infusion site pruritus (itchy/irritated skin)

9. Asthenic conditions (physical weakness or lack of energy)

10. Pyrexia (raised body temperature)

11. Edema (swelling due to fluid retention)

12. Myalgia (muscle aches/pains)

13. Arthralgia (Joint stiffness)

14. Back pain

15. Headache

16. Dizziness

17. Migraine

18. Rash

19. Hypertension

200

If a patient misses a dose with HyQvia when should they be instructed to resume scheduled treatments?

As soon as possible 

200

HyQvia is supplied in a dual vial unit of two single use vials of what? 

10% Ig and rHuPH20

300

HyQvia must be used within this number of months after removal from the fridge. 

3 months 

300

HyQvia was evaluated in THESE 7 subjects in the clinical trail. The available data are too limited to draw safety conclusions for these patients. These patients however are adults, and therefore are NOT off-label. 

Geriatric

300

Severe hypersensitivity reactions may occur, even in patients who had tolerated pervious Ig treatments.  

In the case of a hypersensitivity reaction during an infusion a patient should do what?

Discontinue the HyQvia infusion immediately and institute appropriate treatment. 

300

HyQvia is a 10% Ig and comes in 5 vial sizes (25ml, 50ml, 100ml, 200ml, and 300ml)

How many grams of Ig are in each vial size?

25ml vial = 2.5g Ig

50ml vial = 5.0g Ig

100ml vial = 10.0g Ig

200ml vial = 20.0g Ig

300ml vial = 30.0g Ig

300

What is rHuPH20 and what does it do?

RhuPH20 (recombinant human hyaluronidase) is a protein that facilitates the dispersion and absorption of Ig



400

Patients should visually inspect both components of HyQvia for WHAT prior to administration?

particulate matter and/or discoloration


400

These events have been reported in association with immunoglobulin products. They include myocardial infraction, stroke, pulmonary embolism and deep vein thrombosis. 

Thrombotic and thromboembolic

__

Thrombotic = when blood clots block blood vessels

Thromboembolic = when a piece of a blood clot becomes stock in a blood vessel and largely obstructs blood flow 

400

Human immunoglobulins are produced from human plasma. Despite screening donors and donor donations using plasa tools and other effective manufacturing steps, there is always a possibility of THESE being transmitted when human blood or plasma are administered. 

infective agents (ie viruses and other pathogens). 

Ex. HIV, Hep. B., Hep. C., parvovirus 

400

The recommended dose frequency for HyQvia is once every __ to __ weeks.

once every 3 to 4 weeks 

400

Human Immunoglobulins are prepared from pooled plasma from no fewer than ____ blood donations

1000

500

The dont's: With regards to storage and handling, what shouldn't you do with HyQvia? Provide 3 answers. 


Acceptable answers:

Do not shake

Do not use heating devices to warm up HyQvia to room temperature

Do not freeze

Do not expose UV light

Do not use a vented vial access device to remove rHuPH20 


500

HyQvia is contraindicated (should not be used) for patients with a history of ____, patients with known hypersensitivity to ______  or any of the ingredients in the formulation

patients with a history of anaphylactic or severe system reactions to IgG or hypersensitivity to recombinant human hyaluronidase (rHuPH20)

500

The safety profile of HyQvia was evaluated in four clinic trials with 124 unique patients receiving 3,202 infusions combined.

How many serious adverse reactions occurred during the HyQvia clinical trials.

ZERO

500

There are ___ (# ie 1,2,3) components of HyQvia that must be infused sequentially.

What are they and in what order are they infused?

There are two components of HyQvia, the rHuPH20 and 10% Ig.

The RhuPH20 should be administered first. The full contents of RHuPH20 vial should be administered regardless of whether the full content of Ig is administered. 

500

RhuPh20 is produced by genetically engineering CHO cells using recombinant DNA techniques. What are CHO cells?

Chinese Hamster Ovary cells 

M
e
n
u